Long-term follow-up of children with chronic myeloid leukemia after hematopoietic stem cell transplantation and tyrosine kinase inhibitor therapy

Chronic myeloid leukemia (CML) is a rare malignancy in the pediatric population, accounting for less than 2% of pediatric leukemia.[1] Before the introduction of tyrosine kinase inhibitors (TKI), a...